A new map of glycosaminoglycan and C3b binding sites on factor H

Journal of Immunology

Volumn 181, Issue 4, 2008, Pages 2610-2619

  Schmidt, Christoph Q ^a   Herbert, Andrew P ^a   Kavanagh, David ^a   Gandy, Carina ^a   Fenton, Christopher J ^a   Blaum, Bärbel S ^a   Lyon, Malcolm ^b   Uhrín, Dušan ^a   Barlow, Paul N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; GLYCOSAMINOGLYCAN; HEPARIN; POLYANION; COMPLEMENT; PEPTIDE FRAGMENT; POLYANIONS; POLYMER; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; COMPARATIVE STUDY; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN STRUCTURE; SURFACE PLASMON RESONANCE; BIOSYNTHESIS; CHEMISTRY; COMPLEMENT ALTERNATIVE PATHWAY; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE MAPPING; PROTEIN FOLDING;

BINDING SITES; CHROMATOGRAPHY, AFFINITY; COMPLEMENT C3B; COMPLEMENT FACTOR H; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT SYSTEM PROTEINS; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; POLYMERS; PROTEIN FOLDING; RECOMBINANT PROTEINS;

EID: 53149104792     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.4.2610     Document Type: Article

References (51)

1. Pangburn, M. K., and H. J. Muller-Eberhard. 1984. The alternative pathway of complement. Springer Semin. Immunopathol. 7: 163-192.
2. Weiler, J. M., M. R. Daha, K. F. Austen, and D. T. Fearon. 1976. Control of the amplification convertase of complement by the plasma protein β 1H. Proc. Natl. Acad. Sci. USA 73: 3268-3272.
3. Schmidt, C. Q., A. P. Herbert, H. G. Hocking, D. Uhrin, and P. N. Barlow. 2008. Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clin. Exp. Immunol. 151: 14-24.
4. Kirkitadze, M. D., and P. N. Barlow. 2001. Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol. Rev. 180: 146-161.
5. Walport, M. J. 2001. Complement: first of two parts. N. Engl. J. Med. 344: 1058-1066.
6. Adams, E. M., M. C. Brown, M. Nunge, M. Krych, and J. P. Atkinson. 1991. Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity. J. Immunol. 147: 3005-3011.
7. Fearon, D. T. 1985. Human complement receptors for C3b (CR1) and C3d (CR2). J. Invest. Dermatol. 85: 53s-57s.
8. Lambris, J. D., Z. Lao, T. J. Oglesby, J. P. Atkinson, C. E. Hack, and J. D. Becherer. 1996. Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component. J. Immunol. 156: 4821-4832.
9. Medof, M. E., T. Kinoshita, and V. Nussenzweig. 1984. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J. Exp. Med. 160: 1558-1578.
10. Sim, R. B., and R. G. DiScipio. 1982. Purification and structural studies on the complement-system control protein β 1H (factor H). Biochem. J. 205: 285-293.
11. Pangburn, M. K. 2002. Cutting edge: Localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome. J. Immunol. 169: 4702-4706.
12. Ripoche, J., A. J. Day, A. C. Willis, K. T. Belt, R. D. Campbell, and R. B. Sim. 1986. Partial characterization of human complement factor H by protein and cDNA sequencing: homology with other complement and non-complement proteins. Biosci. Rep. 6: 65-72.
13. Soares, D. C., and P. N. Barlow. 2005. Complement control protein modules in the regulators of complement activation. In Structural Biology of the Complement System. D. Morikis and J. D. Lambris, eds. CRC Press, Taylor & Francis Group, Boca Raton, FL, pp. 19-62.
14. Kirkitadze, M. D., C. Henderson, N. C. Price, S. M. Kelly, N. P. Mullin, J. Parkinson, D. T. Dryden, and P. N. Barlow. 1999. Central modules of the vaccinia virus complement control protein are not in extensive contact. Biochem. J. 344: 167-175.
15. Kirkitadze, M. D., M. Krych, D. Uhrin, D. T. Dryden, B. O. Smith, A. Cooper, X. Wang, R. Hauhart, J. P. Atkinson, and P. N. Barlow. 1999. Independently melting modules and highly structured intermodular junctions within complement receptor type 1. Biochemistry 38: 7019-7031.
16. Ferreira, V. P., A. P. Herbert, H. G. Hocking, P. N. Barlow, and M. K. Pangburn. 2006. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J. Immunol. 177: 6308-6316.
17. Herbert, A. P., D. Uhrin, M. Lyon, M. K. Pangburn, and P. N. Barlow. 2006. Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure. J. Biol. Chem. 281: 16512-16520.
18. Blackmore, T. K., T. A. Sadlon, H. M. Ward, D. M. Lublin, and D. L. Gordon. 1996. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. J. Immunol. 157: 5422-5427.
19. Herbert, A. P., J. A. Deakin, C. Q. Schmidt, B. S. Blaum, C. Egan, V. P. Ferreira, M. K. Pangburn, M. Lyon, D. Uhrin, and P. N. Barlow. 2007. Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J. Biol. Chem. 282: 18960-18968.
20. Herbert, A. P., D. C. Soares, M. K. Pangburn, and P. N. Barlow. 2006. Disease-associated sequence variations in factor H: a structural biology approach. Adv. Exp. Med. Biol. 586: 313-327.
21. Abrera-Abeleda, M. A., C. Nishimura, J. L. Smith, S. Sethi, J. L. McRae, B. F. Murphy, G. Silvestri, C. Skerka, M. Jozsi, P. F. Zipfel, et al. 2006. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J. Med. Genet. 43: 582-589.
22. Warwicker, P., T. H. Goodship, R. L. Donne, Y. Pirson, A. Nicholls, R. M. Ward, P. Turnpenny, and J. A. Goodship. 1998. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int. 53: 836-844.
23. Buddles, M. R., R. L. Donne, A. Richards, J. Goodship, and T. H. Goodship. 2000. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am. J. Hum. Genet. 66: 1721-1722.
24. Richards, A., M. R. Buddles, R. L. Donne, B. S. Kaplan, E. Kirk, M. C. Venning, C. L. Tielemans, J. A. Goodship, and T. H. Goodship. 2001. Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am. J. Hum. Genet. 68: 485-490.
25. Hageman, G. S., D. H. Anderson, L. V. Johnson, L. S. Hancox, A. J. Taiber, L. I. Hardisty, J. L. Hageman, H. A. Stockman, J. D. Borchardt, K. M. Gehrs, et al. 2005. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102: 7227-7232.
26. Klein, R. J., C. Zeiss, E. Y. Chew, J. Y. Tsai, R. S. Sackler, C. Haynes, A. K. Henning, J. P. SanGiovanni, S. M. Mane, S. T. Mayne, et al. 2005. Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
27. Edwards, A. O., R. Ritter III, K. J. Abel, A. Manning, C. Panhuysen, and L. A. Farrer. 2005. Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
28. Haines, J. L., M. A. Hauser, S. Schmidt, W. K. Scott, L. M. Olson, P. Gallins, K. L. Spencer, S. Y. Kwan, M. Noureddine, J. R. Gilbert, et al. 2005. Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421.
29. Prosser, B. E., S. Johnson, P. Roversi, A. P. Herbert, B. S. Blaum, J. Tyrrell, T. A. Jowitt, S. J. Clark, E. Tarelli, D. Uhrin, et al. 2007. Structural basis for complement factor H linked age-related macular degeneration. J. Exp. Med. 204: 2277-2283.
30. Ormsby, R. J., T. S. Jokiranta, T. G. Duthy, K. M. Griggs, T. A. Sadlon, E. Giannakis, and D. L. Gordon. 2006. Localization of the third heparin-binding site in the human complement regulator factor H. Mol. Immunol. 43: 1624-1632.
31. Pangburn, M. K., M. A. Atkinson, and S. Meri. 1991. Localization of the heparin-binding site on complement factor H. J. Biol. Chem. 266: 16847-16853.
32. Jokiranta, T. S., J. Hellwage, V. Koistinen, P. F. Zipfel, and S. Meri. 2000. Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J. Biol. Chem. 275: 27657-27662.
33. Alsenz, J., T. F. Schulz, J. D. Lambris, R. B. Sim, and M. P. Dierich. 1985. Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. Biochem. J. 232: 841-850.
34. Kuhn, S., C. Skerka, and P. F. Zipfel. 1995. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. J. Immunol. 155: 5663-5670.
35. Hocking, H. G., A. P. Herbert, D. Kavanagh, D. C. Soares, V. P. Ferreira, M. K. Pangburn, D. Uhrin, and P. N. Barlow. 2008. Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations. J. Biol. Chem. 283: 9475-9487.
36. Kuhn, S., and P. F. Zipfel. 1996. Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H. Eur. J. Immunol. 26: 2383-2387.
37. Hellwage, J., T. S. Jokiranta, M. A. Friese, T. U. Wolk, E. Kampen, P. F. Zipfel, and S. Meri. 2002. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H. J. Immunol. 169: 6935-6944.
38. Oppermann, M., T. Manuelian, M. Jozsi, E. Brandt, T. S. Jokiranta, S. Heinen, S. Meri, C. Skerka, O. Gotze, and P. F. Zipfel. 2006. The C-terminus of complement regulator factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin. Exp. Immunol. 144: 342-352.
39. Lyon, M., J. A. Deakin, D. Lietha, E. Gherardi, and J. T. Gallagher. 2004. The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay: elucidation of the minimal size of binding and activatory oligosaccharides. J. Biol. Chem. 279: 43560-43567.
40. Catlow, K. R., J. A. Deakin, Z. Wei, M. Delehedde, D. G. Fernig, E. Gherardi, J. T. Gallagher, M. S. Pavao, and M. Lyon. 2007. Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density. J. Biol. Chem. 283: 5235-5248.
41. Meri, S., and M. K. Pangburn. 1990. Discrimination between activators and non-activators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87: 3982-3986.
42. Gordon, D. L., R. M. Kaufman, T. K. Blackmore, J. Kwong, and D. M. Lublin. 1995. Identification of complement regulatory domains in human factor H. J. Immunol. 155: 348-356.
43. Clark, S. J., V. A. Higman, B. Mulloy, S. J. Perkins, S. M. Lea, R. B. Sim, and A. J. Day. 2006. H384 allotypic variant of factor H associated with age-related macular degeneration has different heparin-binding properties from the non-disease-associated form. J. Biol. Chem. 281: 24713-24720.
44. Blackmore, T. K., J. Hellwage, T. A. Sadlon, N. Higgs, P. F. Zipfel, H. M. Ward, and D. L. Gordon. 1998. Identification of the second heparin-binding domain in human complement factor H. J. Immunol. 160: 3342-3348.
45. Sharma, A. K., and M. K. Pangburn. 1996. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl. Acad. Sci. USA 93: 10996-11001.
46. Janssen, B. J., A. Christodoulidou, A. McCarthy, J. D. Lambris, and P. Gros. 2006. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444: 213-216.
47. Janssen, B. J., E. G. Huizinga, H. C. Raaijmakers, A. Roos, M. R. Daha, K. Nilsson-Ekdahl, B. Nilsson, and P. Gros. 2005. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437: 505-511.
48. Aslam, M., and S. J. Perkins. 2001. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. J. Mol. Biol. 309: 1117-1138.
49. Stenberg, E., B. Persson, H. Roos, and C. Urbaniczky. 1991. Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins. J. Colloid Interface Sci. 143: 513-526.
50. Ogata, R. T., P. Mathias, B. M. Bradt, and N. R. Cooper. 1993. Murine C4b-binding protein: mapping of the ligand binding site and the N-terminus of the pre-protein. J. Immunol. 150: 2273-2280.
51. Krych-Goldberg, M., R. E. Hauhart, T. Porzukowiak, and J. P. Atkinson. 2005. Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors. J. Immunol. 175: 4528-4535.